Sphere Fluidics Limited

Sphere Fluidics Limited positions itself as a leader in the integration of droplet microfluidic technology for single cell analysis. With its catchy slogan, "We’re the droplet microfluidic technology company for single cell analysis. We work small so you can think big," the company underscores its mission to revolutionize laboratory workflows by delivering efficient, high-quality solutions.

Founded in 2010, Sphere Fluidics has established a solid reputation within the Biotechnology, Life Sciences, and Pharmaceutical industries. Their offerings are designed to seamlessly integrate into existing laboratory processes, thereby saving time and ensuring reliable results.

Headquartered in the United Kingdom, Sphere Fluidics has attracted significant investment interest. Its latest venture round, dated 28 October 2021, secured a formidable £30.00M from prominent investors such as Sofinnova Partners and Redmile Group. This financial backing not only validates their innovative approach but also positions the company for accelerated growth in a competitive market.